TH34
|
T414170-100mg
|
≥98% |
2196203-96-8 |
100mg
|
¥ 1130.9
|
现货 |
阿拉丁 |
Tinostamustine
|
T414166-5mg
|
≥98% |
1236199-60-2 |
5mg
|
¥ 1825.9
|
现货 |
阿拉丁 |
Tinostamustine
|
T414166-1mg
|
≥98% |
1236199-60-2 |
1mg
|
¥ 567.9
|
现货 |
阿拉丁 |
TP0427736 HCl
|
T414122-5mg
|
≥98% |
864374-00-5 |
5mg
|
¥ 889.9
|
现货 |
阿拉丁 |
TP0427736 HCl
|
T414122-25mg
|
≥98% |
864374-00-5 |
25mg
|
¥ 2338.9
|
现货 |
阿拉丁 |
Tolinapant (ASTX660)
|
T414113-5mg
|
≥98% |
1799328-86-1 |
5mg
|
¥ 839.9
|
现货 |
阿拉丁 |
Tolinapant (ASTX660)
|
T414113-25mg
|
≥98% |
1799328-86-1 |
25mg
|
¥ 2281.9
|
现货 |
阿拉丁 |
Tolinapant (ASTX660)
|
T414113-1mg
|
≥98% |
1799328-86-1 |
1mg
|
¥ 239.9
|
现货 |
阿拉丁 |
Tenalisib (RP6530)
|
T414107-5mg
|
Moligand™, ≥99% |
1639417-53-0 |
5mg
|
¥ 720.9
|
期货,请咨询 |
阿拉丁 |
3-TYP
|
T414087-5mg
|
≥99% |
120241-79-4 |
5mg
|
¥ 61.9
|
现货 |
阿拉丁 |
3-TYP
|
T414087-25mg
|
≥99% |
120241-79-4 |
25mg
|
¥ 184.9
|
现货 |
阿拉丁 |
3-TYP
|
T414087-100mg
|
≥99% |
120241-79-4 |
100mg
|
¥ 617.9
|
现货 |
阿拉丁 |
Tat-beclin 1 (Tat-BECN1) 醋酸盐
|
T414076-5mg
|
≥98% |
1423821-88-8 |
5mg
|
¥ 1099.9
|
期货,请咨询 |
阿拉丁 |
塞利替尼(HMPL-309)
|
T414072-5mg
|
Moligand™, ≥96% |
1353644-70-8 |
5mg
|
¥ 1569.9
|
现货 |
阿拉丁 |
塞利替尼(HMPL-309)
|
T414072-25mg
|
Moligand™, ≥96% |
1353644-70-8 |
25mg
|
¥ 4299.9
|
现货 |
阿拉丁 |
Tucidinostat (Chidamide)
|
T414062-5mg
|
≥98% |
1616493-44-7 |
5mg
|
¥ 127.9
|
期货,请咨询 |
阿拉丁 |
Tucidinostat (Chidamide)
|
T414062-25mg
|
≥98% |
1616493-44-7 |
25mg
|
¥ 325.9
|
期货,请咨询 |
阿拉丁 |
Tucidinostat (Chidamide)
|
T414062-100mg
|
≥98% |
1616493-44-7 |
100mg
|
¥ 940.9
|
期货,请咨询 |
阿拉丁 |
TVB-3664
|
T414060-5mg
|
≥99% |
2097262-58-1 |
5mg
|
¥ 1999.9
|
现货 |
阿拉丁 |
托格列净一水合物(CSG 452 hydrate)
|
T414057-5mg
|
≥98% |
1201913-82-7 |
5mg
|
¥ 754.9
|
现货 |
阿拉丁 |
托格列净一水合物(CSG 452 hydrate)
|
T414057-25mg
|
≥98% |
1201913-82-7 |
25mg
|
¥ 2575.9
|
现货 |
阿拉丁 |
托格列净一水合物(CSG 452 hydrate)
|
T414057-100mg
|
≥98% |
1201913-82-7 |
100mg
|
¥ 5965.9
|
现货 |
阿拉丁 |
TAS-102
|
T414046-5mg
|
≥98% |
733030-01-8 |
5mg
|
¥ 486.9
|
现货 |
阿拉丁 |
TAS-102
|
T414046-25mg
|
≥98% |
733030-01-8 |
25mg
|
¥ 625.9
|
现货 |
阿拉丁 |